Figure S5 from TBK1 Targeting is Identified As a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids | AMiner
Figure S5 from TBK1 Targeting is Identified As a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
原文链接
分享
引用
